Cyanocobalamin - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for cyanocobalamin and what is the scope of patent protection?

Cyanocobalamin is the generic ingredient in fifteen branded drugs marketed by Endo Operations, Pharmacia And Upjohn, Lilly, Watson Labs, Abraxis Pharm, Am Regent, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Lyphomed, Mankind Pharma, Mylan Institutional, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Sanofi Aventis Us, Sola Pharms, Solopak, Somerset Theraps Llc, Vitruvias Therap, Warner Chilcott, West-ward Pharms Int, Wyeth Ayerst, Xiromed, Zydus Pharms, Accord Hlthcare, Merck, Bel Mar, Bristol Myers Squibb, Savage Labs, Bayer Hlthcare, Lupin, Padagis Israel, West Ward, Ge Healthcare, and Armour Pharm, and is included in forty-five NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cyanocobalamin. Twenty-four suppliers are listed for this compound.

Summary for cyanocobalamin

US Patents:	6
Tradenames:	15
Applicants:	40
NDAs:	45
Drug Master File Entries:	9
Finished Product Suppliers / Packagers:	24
Raw Ingredient (Bulk) Api Vendors:	79
Clinical Trials:	39
Patent Applications:	3,563
Drug Prices:	Drug price trends for cyanocobalamin
Drug Sales Revenues:	Drug sales revenues for cyanocobalamin
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for cyanocobalamin
What excipients (inactive ingredients) are in cyanocobalamin?	cyanocobalamin excipients list
DailyMed Link:	cyanocobalamin at DailyMed

See drug prices for cyanocobalamin

Drug Sales Revenue Trends for cyanocobalamin

See drug sales revenues for cyanocobalamin

Recent Clinical Trials for cyanocobalamin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fundação Educacional Serra dos Órgãos	Phase 4
University of Kansas Medical Center	Phase 2
Tanta University	Phase 3

See all cyanocobalamin clinical trials

Pharmacology for cyanocobalamin

Drug Class	Vitamin B12

Anatomical Therapeutic Chemical (ATC) Classes for cyanocobalamin

B03BA	Vitamin B12 (cyanocobalamin and analogues)
B03B	VITAMIN B12 AND FOLIC ACID
B03	ANTIANEMIC PREPARATIONS
B	Blood and blood forming organs

Paragraph IV (Patent) Challenges for CYANOCOBALAMIN

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
NASCOBAL	Nasal Spray	cyanocobalamin	500 mcg/spray	021642	1	2017-04-28

US Patents and Regulatory Information for cyanocobalamin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Savage Labs	RUVITE	cyanocobalamin	INJECTABLE;INJECTION	080570-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Labs Ltd	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	204829-001	Jun 5, 2017	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sola Pharms	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	215417-001	Apr 15, 2022	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	083120-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bayer Hlthcare	VI-TWEL	cyanocobalamin	INJECTABLE;INJECTION	007012-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for cyanocobalamin

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Operations	NASCOBAL	cyanocobalamin	GEL, METERED;NASAL	019722-001	Nov 5, 1996	⤷ Sign Up	⤷ Sign Up
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Sign Up	⤷ Sign Up
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Sign Up	⤷ Sign Up
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Sign Up	⤷ Sign Up
Endo Operations	NASCOBAL	cyanocobalamin	SPRAY, METERED;NASAL	021642-001	Jan 31, 2005	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.